ArticleCancers2022

Neratinib and Capecitabine for the Treatment of Leptomeningeal Metastases from HER2-Positive Breast Cancer: A Series in the Setting of a Compassionate Program.

Alessia Pellerino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.